Medpace

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medpace and other ETFs, options, and stocks.

About MEDP

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. 

CEO
August James Troendle
CEOAugust James Troendle
Employees
5,900
Employees5,900
Headquarters
Cincinnati, Ohio
HeadquartersCincinnati, Ohio
Founded
1992
Founded1992
Employees
5,900
Employees5,900

MEDP Key Statistics

Market cap
15.77B
Market cap15.77B
Price-Earnings ratio
39.02
Price-Earnings ratio39.02
Dividend yield
Dividend yield
Average volume
281.52K
Average volume281.52K
High today
$563.68
High today$563.68
Low today
$553.32
Low today$553.32
Open price
$557.90
Open price$557.90
Volume
252.91K
Volume252.91K
52 Week high
$626.26
52 Week high$626.26
52 Week low
$250.05
52 Week low$250.05

Stock Snapshot

With a market cap of 15.77B, Medpace(MEDP) trades at $559.13. The stock has a price-to-earnings ratio of 39.02.

On 2025-12-15, Medpace(MEDP) stock traded between a low of $553.32 and a high of $563.68. Shares are currently priced at $559.13, which is +1.1% above the low and -0.8% below the high.

The Medpace(MEDP)'s current trading volume is 252.91K, compared to an average daily volume of 281.52K.

In the last year, Medpace(MEDP) shares hit a 52-week high of $626.26 and a 52-week low of $250.05.

In the last year, Medpace(MEDP) shares hit a 52-week high of $626.26 and a 52-week low of $250.05.

MEDP News

Simply Wall St 1d
How Acquisition-Light Revenue Growth And EPS Leverage At Medpace Holdings Has Changed Its Investment Story

In the past quarter, Medpace Holdings reported a 23.7% year-over-year revenue increase, underscoring strong organic growth in its clinical research services for...

How Acquisition-Light Revenue Growth And EPS Leverage At Medpace Holdings Has Changed Its Investment Story
Yahoo Finance 2d
How Medpace’s Q3 2025 Surge and Buybacks Strategy Could Impact Medpace Holdings Investors - Yahoo Finance

...

How Medpace’s Q3 2025 Surge and Buybacks Strategy Could Impact Medpace Holdings Investors - Yahoo Finance

Analyst ratings

62%

of 13 ratings
Buy
7.7%
Hold
61.5%
Sell
30.8%

People also own

Based on the portfolios of people who own MEDP. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.